Migraine practice patterns among neurologists

Richard B. Lipton, M. E. Bigal, S. R. Rush, J. P. Yenkosky, J. N. Liberman, J. D. Bartleson, S. D. Silberstein

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objective: To assess the attitudes, knowledge, and practice patterns of US neurologists regarding migraine management relative to the US Headache Consortium Guidelines (the Guidelines). Methods: Two samples of 600 neurologists each were selected from the American Academy of Neurology membership database. The first group received a Migraine Attitudes, Knowledge, and Practice Patterns (MKAPP) Survey. The second group received a Clinical Vignette (CV) Survey, presenting two patient histories and correspondent questions. Results: The MKAPP Survey showed that most neurologists felt that migraine was primarily a disease of the brain with a well-established neurobiological basis (69%) and an important part of their practice (60%). Most (53%) indicated that they routinely used neuroimaging in evaluating severe headache, an approach not recommended by the Guidelines. Most favored acute treatment limits, but 36% did not agree with the Guidelines that acute treatment should be limited to 2 or 3 days/week. In the CV Survey, for vignette 1, most (91%) correctly diagnosed migraine, 31% requested neuroimaging in the absence of indications, 64% appropriately recommended a triptan, and 45% recommended a preventive medication in the absence of indications. For vignette 2, 78% diagnosed migraine, 71% appropriately ordered neuroimaging, 80% appropriately recommended a preventive medication, and 38% prescribed a triptan in face of clear contraindication. Conclusions: Educational initiatives aiming to increase the awareness of the Guidelines among neurologists should highlight the full range of migraine symptoms that support the diagnosis, appropriate use of neuroimaging, indications for preventive treatments, issues of triptan cardiovascular safety, and preventing rebound headaches.

Original languageEnglish (US)
Pages (from-to)1926-1931
Number of pages6
JournalNeurology
Volume62
Issue number11
StatePublished - Jun 8 2004

Fingerprint

Migraine Disorders
Tryptamines
Health Knowledge, Attitudes, Practice
Neuroimaging
Guidelines
Headache
Brain Diseases
Neurologists
Therapeutics
Databases
Safety
Surveys and Questionnaires

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lipton, R. B., Bigal, M. E., Rush, S. R., Yenkosky, J. P., Liberman, J. N., Bartleson, J. D., & Silberstein, S. D. (2004). Migraine practice patterns among neurologists. Neurology, 62(11), 1926-1931.

Migraine practice patterns among neurologists. / Lipton, Richard B.; Bigal, M. E.; Rush, S. R.; Yenkosky, J. P.; Liberman, J. N.; Bartleson, J. D.; Silberstein, S. D.

In: Neurology, Vol. 62, No. 11, 08.06.2004, p. 1926-1931.

Research output: Contribution to journalArticle

Lipton, RB, Bigal, ME, Rush, SR, Yenkosky, JP, Liberman, JN, Bartleson, JD & Silberstein, SD 2004, 'Migraine practice patterns among neurologists', Neurology, vol. 62, no. 11, pp. 1926-1931.
Lipton RB, Bigal ME, Rush SR, Yenkosky JP, Liberman JN, Bartleson JD et al. Migraine practice patterns among neurologists. Neurology. 2004 Jun 8;62(11):1926-1931.
Lipton, Richard B. ; Bigal, M. E. ; Rush, S. R. ; Yenkosky, J. P. ; Liberman, J. N. ; Bartleson, J. D. ; Silberstein, S. D. / Migraine practice patterns among neurologists. In: Neurology. 2004 ; Vol. 62, No. 11. pp. 1926-1931.
@article{e3eb4f3b0f46456cacc5d3be100e5223,
title = "Migraine practice patterns among neurologists",
abstract = "Objective: To assess the attitudes, knowledge, and practice patterns of US neurologists regarding migraine management relative to the US Headache Consortium Guidelines (the Guidelines). Methods: Two samples of 600 neurologists each were selected from the American Academy of Neurology membership database. The first group received a Migraine Attitudes, Knowledge, and Practice Patterns (MKAPP) Survey. The second group received a Clinical Vignette (CV) Survey, presenting two patient histories and correspondent questions. Results: The MKAPP Survey showed that most neurologists felt that migraine was primarily a disease of the brain with a well-established neurobiological basis (69{\%}) and an important part of their practice (60{\%}). Most (53{\%}) indicated that they routinely used neuroimaging in evaluating severe headache, an approach not recommended by the Guidelines. Most favored acute treatment limits, but 36{\%} did not agree with the Guidelines that acute treatment should be limited to 2 or 3 days/week. In the CV Survey, for vignette 1, most (91{\%}) correctly diagnosed migraine, 31{\%} requested neuroimaging in the absence of indications, 64{\%} appropriately recommended a triptan, and 45{\%} recommended a preventive medication in the absence of indications. For vignette 2, 78{\%} diagnosed migraine, 71{\%} appropriately ordered neuroimaging, 80{\%} appropriately recommended a preventive medication, and 38{\%} prescribed a triptan in face of clear contraindication. Conclusions: Educational initiatives aiming to increase the awareness of the Guidelines among neurologists should highlight the full range of migraine symptoms that support the diagnosis, appropriate use of neuroimaging, indications for preventive treatments, issues of triptan cardiovascular safety, and preventing rebound headaches.",
author = "Lipton, {Richard B.} and Bigal, {M. E.} and Rush, {S. R.} and Yenkosky, {J. P.} and Liberman, {J. N.} and Bartleson, {J. D.} and Silberstein, {S. D.}",
year = "2004",
month = "6",
day = "8",
language = "English (US)",
volume = "62",
pages = "1926--1931",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Migraine practice patterns among neurologists

AU - Lipton, Richard B.

AU - Bigal, M. E.

AU - Rush, S. R.

AU - Yenkosky, J. P.

AU - Liberman, J. N.

AU - Bartleson, J. D.

AU - Silberstein, S. D.

PY - 2004/6/8

Y1 - 2004/6/8

N2 - Objective: To assess the attitudes, knowledge, and practice patterns of US neurologists regarding migraine management relative to the US Headache Consortium Guidelines (the Guidelines). Methods: Two samples of 600 neurologists each were selected from the American Academy of Neurology membership database. The first group received a Migraine Attitudes, Knowledge, and Practice Patterns (MKAPP) Survey. The second group received a Clinical Vignette (CV) Survey, presenting two patient histories and correspondent questions. Results: The MKAPP Survey showed that most neurologists felt that migraine was primarily a disease of the brain with a well-established neurobiological basis (69%) and an important part of their practice (60%). Most (53%) indicated that they routinely used neuroimaging in evaluating severe headache, an approach not recommended by the Guidelines. Most favored acute treatment limits, but 36% did not agree with the Guidelines that acute treatment should be limited to 2 or 3 days/week. In the CV Survey, for vignette 1, most (91%) correctly diagnosed migraine, 31% requested neuroimaging in the absence of indications, 64% appropriately recommended a triptan, and 45% recommended a preventive medication in the absence of indications. For vignette 2, 78% diagnosed migraine, 71% appropriately ordered neuroimaging, 80% appropriately recommended a preventive medication, and 38% prescribed a triptan in face of clear contraindication. Conclusions: Educational initiatives aiming to increase the awareness of the Guidelines among neurologists should highlight the full range of migraine symptoms that support the diagnosis, appropriate use of neuroimaging, indications for preventive treatments, issues of triptan cardiovascular safety, and preventing rebound headaches.

AB - Objective: To assess the attitudes, knowledge, and practice patterns of US neurologists regarding migraine management relative to the US Headache Consortium Guidelines (the Guidelines). Methods: Two samples of 600 neurologists each were selected from the American Academy of Neurology membership database. The first group received a Migraine Attitudes, Knowledge, and Practice Patterns (MKAPP) Survey. The second group received a Clinical Vignette (CV) Survey, presenting two patient histories and correspondent questions. Results: The MKAPP Survey showed that most neurologists felt that migraine was primarily a disease of the brain with a well-established neurobiological basis (69%) and an important part of their practice (60%). Most (53%) indicated that they routinely used neuroimaging in evaluating severe headache, an approach not recommended by the Guidelines. Most favored acute treatment limits, but 36% did not agree with the Guidelines that acute treatment should be limited to 2 or 3 days/week. In the CV Survey, for vignette 1, most (91%) correctly diagnosed migraine, 31% requested neuroimaging in the absence of indications, 64% appropriately recommended a triptan, and 45% recommended a preventive medication in the absence of indications. For vignette 2, 78% diagnosed migraine, 71% appropriately ordered neuroimaging, 80% appropriately recommended a preventive medication, and 38% prescribed a triptan in face of clear contraindication. Conclusions: Educational initiatives aiming to increase the awareness of the Guidelines among neurologists should highlight the full range of migraine symptoms that support the diagnosis, appropriate use of neuroimaging, indications for preventive treatments, issues of triptan cardiovascular safety, and preventing rebound headaches.

UR - http://www.scopus.com/inward/record.url?scp=2942594548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942594548&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 1926

EP - 1931

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -